Analysis Of Veterinary Drug Raw Material Market

- Jan 23, 2019-

Analysis of Veterinary Drug Raw Material Market in China in the 4th Week of 2019

 

Penicillins

Amoxicillin,the market supply is tight, manufacturers adjust prices.

Ampicillin, Ampicillin Sodium, Stable Operation.

Penicillin potassium: penicillin sodium, penicillin potassium industrial salt, recent attention increased, stable prices.

Aminoglycosides:Kanamycin Monosulfate, recent price shock adjustment, market quotation range is large.

Neomycin sulfate, high-level operation,shortage of supply, we can pay more attention to it.

Gentamycin Sulfate, Price Shock.

Ampromycin sulfate, stable price, tight supply,  stable price.

Tetracycline and Chloramphenicols:

Oxytetracycline, oxytetracycline hydrochloride, recent market transactions are weak,price fluctuations downward. 

Doxycycline, near the end of recent years, the price is relatively stable.  It can be properly stocked.

Flufenicol, with stable prices and low market turnover, is mainly on the sidelines.

Macrolactones:

Erythromycin thiocyanate, small price fluctuation.

Temicocin and Temicocin Phosphate are in continuous supply with price fluctuation. The price difference between Temicocin Phosphate and Temicocin Phosphate is not big.

Tylosin tartrate, prices continue to oscillate downward.

Cephalosporins:Ceftiofur Sodium and Cefquinoxime Sulfate, Stable Operation.

Vitamins:

VA, active market delivery, weak price collation.

B1, Weak Finishing

B2, price slightly callback.

VC, stable operation in the near future, low price.

D3. Source relief, positive market shipment, concussion callback.

VE, weak operation.

K3, market transaction is weak, price is stable and tidy up.

Calcium pantothenate, increased market attention, active purchasing and marketing, strong operation, sustainable attention.

Nicotinamide, stable.

 

Previous:Prices Of Major APIs At The Beginning Of 2019 Next:Chemical Raw Materials In The Three Quarter Of The Performance Is Good, Vitamin Family Led